Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Summary for Patients
space
 arrow  Summary for Patients (PDF)
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Halligan, S. C.
space
  arrow  Friedman, P. A.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

BRIEF COMMUNICATION

The Natural History of Lone Atrial Flutter

right arrow Sean C. Halligan, MD; Bernard J. Gersh, MBChB, DPhil; Robert D. Brown, Jr., MD; A. Gabriela Rosales, MS; Thomas M. Munger, MD; Win-Kuang Shen, MD; Stephen C. Hammill, MD; and Paul A. Friedman, MD

17 February 2004 | Volume 140 Issue 4 | Pages 265-268

Background: The natural history of atrial flutter is not well defined.

Objective: To report the risk for stroke, conversion to atrial fibrillation, and anticoagulation for lone atrial flutter.

Design: Retrospective cohort analysis.

Setting: A clinically based longitudinal study of inpatients and outpatients with atrial flutter.

Patients: The authors compared the stroke rate in 59 patients with atrial flutter with rates in a sample in which age- and sex-specific ischemic cerebrovascular event rates were determined and in a sample of nonhypertensive patients with lone atrial fibrillation. The risk for developing atrial fibrillation after presenting with atrial flutter is also reported.

Measurements: Electrocardiograms and clinical data were collected and reviewed for each study participant.

Results: After adjustment for age and sex, patients with atrial flutter had a higher incidence of thromboembolic events than the sample control patients and patients with atrial fibrillation. Atrial fibrillation developed in 56% of patients with atrial flutter.

Conclusions: Lone atrial flutter has a stroke risk at least as high as lone atrial fibrillation and carries a higher risk for subsequent development of atrial fibrillation than in the general population. Anticoagulation should be considered for all patients with atrial flutter who are older than 65 years of age.


Editors' Notes
space

Context

  • While the adverse consequences of atrial fibrillation have received much attention, we know little about the outcomes of people with lone atrial flutter.

Contribution

  • Among 59 patients with lone atrial flutter cared for at the Mayo Clinic between 1965 and 1995, 33 developed atrial fibrillation and 19 sustained a cerebrovascular event over an average follow-up of 10 years. The rate of thromboembolic events observed in this sample of patients with lone atrial flutter was at least as high as that observed in patients with atrial fibrillation.

Cautions

  • This observational study cannot tell us whether treatment for atrial flutter and anticoagulation would improve outcomes for people with lone atrial flutter.

–The Editors

 

Author and Article Information
space

From the Mayo Clinic, Rochester, Minnesota.

Grant Support: Through support from the Mayo Foundation.

Potential Financial Conflicts of Interest: None disclosed.

Corresponding Author: Paul A. Friedman, MD, Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.

Current Author Addresses: Drs. Halligan, Brown, Munger, Shen, Hammill, Friedman, and Gersh and Ms. Rosales: Mayo Clinic, 200 First Street SW, Rochester, MN 55905.

Author Contributions: Conception and design: S.C. Halligan, B.J. Gersh, R.D. Brown Jr., T.M. Munger, S.C. Hammill, P.A. Friedman.

Analysis and interpretation of the data: S.C. Halligan, B.J. Gersh, R.D. Brown Jr, A.G. Rosales, T.M. Munger, S.C. Hammill, P.A. Friedman.

Drafting of the article: S.C. Halligan, B.J. Gersh, R.D. Brown Jr., S.C. Hammill,

Critical revision of the article for important intellectual content: S.C. Halligan, B.J. Gersh, R.D. Brown Jr., A.G. Rosales, W.-K. Shen, S.C. Hammill, P.A. Friedman.

Final approval of the article: B.J. Gersh, R.D. Brown Jr., T.M. Munger, W.-K. Shen, S.C. Hammill, P.A. Friedman.

Provision of study materials or patients: S.C. Halligan.

Statistical expertise: A.G. Rosales.

Obtaining of funding: S.C. Halligan.

Administrative, technical, or logistic support: R.D. Brown Jr., S.C. Hammill, P.A. Friedman.

Collection and assembly of data: S.C. Halligan.


Related articles in Annals:

Summaries for Patients
Outcomes of Patients with Lone Atrial Flutter
Annals 2004 140: I-55. [Full Text]  



This article has been cited by other articles:


Home page
EuropaceHome page
J. J. Blanc, J. Almendral, M. Brignole, M. Fatemi, K. Gjesdal, E. Gonzalez-Torrecilla, P. Kulakowski, G. Y.H. Lip, D. Shah, C. Wolpert, et al.
Consensus document on antithrombotic therapy in the setting of electrophysiological procedures
Europace, May 1, 2008; 10(5): 513 - 527.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Doufekias, A. Z. Segal, and J. R. Kizer
Cardiogenic and aortogenic brain embolism.
J. Am. Coll. Cardiol., March 18, 2008; 51(11): 1049 - 1059.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S. M. Hailpern, M. Ho, V. Howard, B. Kissela, et al.
Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Circulation, January 29, 2008; 117(4): e25 - e146.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Y.-J. Shen, J. F. Yao, S. S. Brar, M. B. Jorgensen, and W. Chen
Racial/Ethnic Differences in the Risk of Intracranial Hemorrhage Among Patients With Atrial Fibrillation
J. Am. Coll. Cardiol., July 24, 2007; 50(4): 309 - 315.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Frost
Lone Atrial Fibrillation: Good, Bad, or Ugly?
Circulation, June 19, 2007; 115(24): 3040 - 3041.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
J. Heeringa, D. A. M. van der Kuip, A. Hofman, J. A. Kors, F. J. A. van Rooij, G. Y. H. Lip, and J. C. M. Witteman
Subclinical Atherosclerosis and Risk of Atrial Fibrillation: The Rotterdam Study
Arch Intern Med, February 26, 2007; 167(4): 382 - 387.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. Rosamond, K. Flegal, G. Friday, K. Furie, A. Go, K. Greenlund, N. Haase, M. Ho, V. Howard, B. Kissela, et al.
Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Circulation, February 6, 2007; 115(5): e69 - e171.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
D J H McCabe and R D Rakhit
Antithrombotic and interventional treatment options in cardioembolic transient ischaemic attack and ischaemic stroke
J. Neurol. Neurosurg. Psychiatry, January 1, 2007; 78(1): 14 - 24.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Da Costa, J. Thevenin, F. Roche, C. Romeyer-Bouchard, L. Abdellaoui, M. Messier, L. Denis, E. Faure, R. Gonthier, G. Kruszynski, et al.
Results From the Loire-Ardeche-Drome-Isere-Puy-de-Dome (LADIP) Trial on Atrial Flutter, a Multicentric Prospective Randomized Study Comparing Amiodarone and Radiofrequency Ablation After the First Episode of Symptomatic Atrial Flutter
Circulation, October 17, 2006; 114(16): 1676 - 1681.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. Heeringa, D. A.M. van der Kuip, A. Hofman, J. A. Kors, G. van Herpen, B. H.Ch. Stricker, T. Stijnen, G. Y.H. Lip, and J. C.M. Witteman
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study
Eur. Heart J., April 2, 2006; 27(8): 949 - 953.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. A. Elesber, A. G. Rosales, R. M. Herges, W.-K. Shen, B. S. Moon, J. F. Malouf, N. M. Ammash, V. Somers, D. O. Hodge, B. J. Gersh, et al.
Relapse and mortality following cardioversion of new-onset vs. recurrent atrial fibrillation and atrial flutter in the elderly
Eur. Heart J., April 1, 2006; 27(7): 854 - 860.
[Abstract] [Full Text] [PDF]


Home page
DTBHome page
Drugs to prevent vascular events after stroke
DTB, July 1, 2005; 43(7): 53 - 56.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
M. F. Scholten, A. S. Thornton, J. M. Mekel, P. J. Koudstaal, and L. J. Jordaens
Anticoagulation in atrial fibrillation and flutter
Europace, January 1, 2005; 7(5): 492 - 499.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
T. J. Wang, H. Parise, D. Levy, R. B. D'Agostino Sr, P. A. Wolf, R. S. Vasan, and E. J. Benjamin
Obesity and the Risk of New-Onset Atrial Fibrillation
JAMA, November 24, 2004; 292(20): 2471 - 2477.
[Abstract] [Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
Natural History of Lone Atrial Flutter
Journal Watch Cardiology, April 9, 2004; 2004(409): 2 - 2.
[Full Text]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2004 by the American College of Physicians.